Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES SUVEN LIFE SCIENCES DIVIS LABORATORIES/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 29.6 -15.0 - View Chart
P/BV x 7.6 14.6 51.7% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
SUVEN LIFE SCIENCES
Mar-22
DIVIS LABORATORIES/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs5,425124 4,360.9%   
Low Rs3,56270 5,056.1%   
Sales per share (Unadj.) Rs337.50.8 41,427.7%  
Earnings per share (Unadj.) Rs111.5-8.4 -1,328.9%  
Cash flow per share (Unadj.) Rs123.3-8.1 -1,523.6%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs441.86.6 6,680.3%  
Shares outstanding (eoy) m265.47145.38 182.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.3119.6 11.1%   
Avg P/E ratio x40.3-11.6 -347.1%  
P/CF ratio (eoy) x36.5-12.0 -302.7%  
Price / Book Value ratio x10.214.7 69.0%  
Dividend payout %26.90-   
Avg Mkt Cap Rs m1,192,89014,164 8,422.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9,462210 4,501.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598118 75,648.7%  
Other income Rs m1,15953 2,179.8%   
Total revenues Rs m90,757172 52,885.8%   
Gross profit Rs m38,811-1,222 -3,174.8%  
Depreciation Rs m3,11544 7,091.1%   
Interest Rs m207 298.5%   
Profit before tax Rs m36,835-1,220 -3,019.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2310-   
Profit after tax Rs m29,605-1,220 -2,426.7%  
Gross profit margin %43.3-1,032.2 -4.2%  
Effective tax rate %19.60-   
Net profit margin %33.0-1,030.0 -3.2%  
BALANCE SHEET DATA
Current assets Rs m96,1041,605 5,988.1%   
Current liabilities Rs m24,5441,022 2,401.3%   
Net working cap to sales %79.9492.1 16.2%  
Current ratio x3.91.6 249.4%  
Inventory Days Days91,402 0.6%  
Debtors Days Days987400 246.9%  
Net fixed assets Rs m50,087414 12,086.7%   
Share capital Rs m531145 365.2%   
"Free" reserves Rs m116,751816 14,306.5%   
Net worth Rs m117,282961 12,198.4%   
Long term debt Rs m00-   
Total assets Rs m146,1912,019 7,239.6%  
Interest coverage x1,842.8-181.1 -1,017.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.1 1,044.9%   
Return on assets %20.3-60.1 -33.7%  
Return on equity %25.2-126.9 -19.9%  
Return on capital %31.4-126.2 -24.9%  
Exports to sales %044.7 0.0%   
Imports to sales %19.7933.6 2.1%   
Exports (fob) Rs mNA53 0.0%   
Imports (cif) Rs m17,6761,106 1,598.4%   
Fx inflow Rs m78,44553 148,149.8%   
Fx outflow Rs m17,9531,106 1,623.6%   
Net fx Rs m60,492-1,053 -5,745.5%   
CASH FLOW
From Operations Rs m19,118-1,275 -1,499.0%  
From Investments Rs m-21,949-222 9,874.1%  
From Financial Activity Rs m-5,3241,457 -365.5%  
Net Cashflow Rs m-8,156-41 20,013.7%  

Share Holding

Indian Promoters % 51.9 65.0 79.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 0.6 6,030.0%  
FIIs % 15.4 0.5 3,208.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 35.0 137.2%  
Shareholders   379,257 80,116 473.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Divis Laboratories vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Suven Life Sciences Share Price Performance

Period Divis Laboratories Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.11% -1.83% 0.33%
1-Month -7.18% 3.78% 0.28%
1-Year -30.23% -32.02% -6.55%
3-Year CAGR 23.73% -40.54% 20.31%
5-Year CAGR 26.30% -20.51% 10.96%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Suven Life Sciences the stake stands at 65.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.